Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p63 in Primary Cutaneous Carcinosarcoma.

Ki-Young Suh1, Mario Lacouture, Pedram Gerami

  • 1Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. kiyoungsuh@gmail.com

The American Journal of Dermatopathology
|August 2, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Journal of drugs in dermatology : JDD·2026
Same author

Sparse Insurance and Alopecia Information Availability Among New York City Wig Providers: A Cross-Sectional Study.

Journal of the American Academy of Dermatology·2026
Same author

Clinical, morphological, and genomic features of FGFR fusion Spitz neoplasms.

Pathology·2026
Same author

ERBB fusions in Spitz neoplasms, expanding the spectrum of Spitz-associated genomic fusions.

Pathology·2026
Same author

Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous Tumors.

The American journal of surgical pathology·2026
Same author

Use of ancillary studies in pediatric spitzoid neoplasms: A retrospective cohort study.

Journal of the American Academy of Dermatology·2026

This study highlights p63 and AE1/AE3 immunohistochemistry for diagnosing rare primary cutaneous carcinosarcomas (PCCs). Combining these markers improves sensitivity in identifying epithelial cells across various differentiation states in PCC diagnosis.

Area of Science:

  • Dermatopathology
  • Oncology
  • Immunohistochemistry

Background:

  • Primary cutaneous carcinosarcomas (PCCs) are rare malignant neoplasms with biphasic epithelial and mesenchymal components.
  • Diagnosis can be challenging when the biphasic nature is not apparent.
  • Immunohistochemistry is crucial for differentiating epithelial and mesenchymal elements.

Observation:

  • AE1/AE3, a common epithelial marker, may show weak expression in poorly differentiated cells.
  • p63, a p53 homologue, is expressed in poorly differentiated epithelial cells.
  • Three PCC cases were analyzed using AE1/AE3 and p63 staining.

Findings:

  • Epithelial areas were positive for both AE1/AE3 and p63.
  • Sarcomatous areas were negative for both markers.

Related Experiment Videos

  • Poorly differentiated epithelial cells, difficult to identify morphologically, were positive for p63 but negative for AE1/AE3.
  • Transitional areas showed positivity for p63 alone.

    • Implications:

    • Using both p63 and AE1/AE3 enhances diagnostic sensitivity for PCCs by detecting epithelial cells across differentiation states.
    • The observed staining patterns support the conversion theory of PCC development.
    • This combined immunohistochemical approach aids in accurate PCC diagnosis.